12 reports

CANADIAN KEY OPINION LEADER MOST OF THE CURRENT PHASE III REGISTRATIONAL TRIALS THAT ARE INVESTIGATING COMBINATION THERAPIES INVOLVE AT LEAST ONE ANTI-CD## MONOCLONAL ANTIBODY.

  • Monoclonal Antibody
  • Canada
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group

Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Revie

  • Medical Biotechnology
  • Monoclonal Antibody
  • Canada
  • Forecast
  • Market Size

Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Revie

  • Medical Biotechnology
  • Monoclonal Antibody
  • Switzerland
  • Forecast
  • Market Size

Its molecules product pipeline includes UB- ##, a monoclonal antibody for AIDS treatment; and UB-##, an anti-herpes simplex virus (HSV) monoclonal antibody.

  • Allergy Drug
  • Monoclonal Antibody
  • Canada
  • Switzerland
  • Product Initiative
  • PARTNERSHIPS
  • VENTURE FINANCING

The additional unpaid payments may, however, be accelerated by either party at any time after ## July 2019.

  • Monoclonal Antibody
  • Pharmaceutical
  • Switzerland
  • Company
  • Novimmune SA
  • VENTURE FINANCING
  • LICENSING AGREEMENTS

It is a recombinant humanized monoclonal antibody and targets HER## (human epidermal growth factor receptor ##).

  • Medical Biotechnology
  • Monoclonal Antibody
  • Canada
  • Deals & Alliance
  • PlantForm Corporation

Mepolizumab is a monoclonal IgG antibody targeting interleukin-##.

  • Monoclonal Antibody
  • Therapy
  • Canada
  • Switzerland
  • Product Initiative

In July 2013, Radboud University completed a Phase I/ II trial of Increasing doses of Lutetium-## labeled chimeric monoclonal antibody cg## in patients with advanced renal cancer.

  • Brain Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Canada
  • Product Initiative
  • LICENSING AGREEMENTS

The drug candidate is a monoclonal antibody and acts by targeting cells expressing mucin-##.

  • Monoclonal Antibody
  • Pharmaceutical
  • Canada
  • Company
  • Quest PharmaTech Inc.
  • Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Product Development Milestones

Monoclonal antibodies to beta## integrin ameliorate colitis.

  • Monoclonal Antibody
  • Targeted Therapy
  • Canada
  • Switzerland
  • Takeda Pharmaceutical Company Limited

Other Developmental Activities Product Description Monoclonal Antibody for Oncology and Inflammation Monoclonal antibody is under development for the treatment of cancer and inflammation.

  • Monoclonal Antibody
  • Therapy
  • Switzerland
  • Company Operations
  • Delenex Therapeutics AG

When put in test tubes, these antibodies gobbled up cocaine.

  • Monoclonal Antibody
  • Vaccine
  • Canada
  • Company Operations
  • Immunovaccine Inc.